These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25054134)

  • 1. Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents.
    Mohamed MS; Ali SA; Abdelaziz DH; Fathallah SS
    Biomed Res Int; 2014; 2014():249780. PubMed ID: 25054134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds.
    Fatahala SS; Mahgub S; Taha H; Abd-El Hameed RH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):809-817. PubMed ID: 29708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
    Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARĪ³ and SUR agonists.
    El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
    Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
    Goel A; Agarwal N; Singh FV; Sharon A; Tiwari P; Dixit M; Pratap R; Srivastava AK; Maulik PR; Ram VJ
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1089-92. PubMed ID: 14980641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
    Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
    Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
    Singh FV; Chaurasia S; Joshi MD; Srivastava AK; Goel A
    Bioorg Med Chem Lett; 2007 May; 17(9):2425-9. PubMed ID: 17336063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties.
    Jawale DV; Pratap UR; Rahuja N; Srivastava AK; Mane RA
    Bioorg Med Chem Lett; 2012 Jan; 22(1):436-9. PubMed ID: 22123321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new thiazolylmethoxyphenyl pyrimidines and antihyperglycemic evaluation of the pyrimidines, analogues isoxazolines and pyrazolines.
    Bhosle MR; Deshmukh AR; Pal S; Srivastava AK; Mane RA
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2442-6. PubMed ID: 25937008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of novel diaryl pyrrolopyrimidine and pyrrolothiazine derivatives as inhibitors of tumor necrosis factor stimulated gene-14 (TSG-14) production.
    Hilmy KM; Soliman DH; Shahin EB; El-Deeb HS; El-Kousy SM
    Eur J Med Chem; 2014 May; 78():419-24. PubMed ID: 24704614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
    Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
    Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
    Imran M; Yar MS; Khan SA
    Acta Pol Pharm; 2009; 66(1):51-6. PubMed ID: 19226969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and antihyperglycemic activity of novel oxazolidine derivatives.
    Selvam TP; Kumar PV; Ramu P; Kumar AS
    Arch Pharm Res; 2011 Jun; 34(6):887-91. PubMed ID: 21725808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcone based aryloxypropanolamines as potential antihyperglycemic agents.
    Shukla P; Singh AB; Srivastava AK; Pratap R
    Bioorg Med Chem Lett; 2007 Feb; 17(3):799-802. PubMed ID: 17095211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-anilino-4-substituted-7H-pyrrolopyrimidines as PDK1 inhibitors.
    O'Brien NJ; Brzozowski M; Buskes MJ; Deady LW; Abbott BM
    Bioorg Med Chem; 2014 Aug; 22(15):3879-86. PubMed ID: 25012568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines.
    Dwivedi AP; Kumar S; Varshney V; Singh AB; Srivastava AK; Sahu DP
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2301-5. PubMed ID: 18353644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines.
    Satyanarayana M; Tiwari P; Tripathi BK; Srivastava AK; Pratap R
    Bioorg Med Chem; 2004 Mar; 12(5):883-9. PubMed ID: 14980600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in post-prandial hyperglycemic excursion through alpha-glucosidase inhibition by beta-acetamido carbonyl compounds.
    Tiwari AK; Kumbhare RM; Agawane SB; Ali AZ; Kumar KV
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4130-2. PubMed ID: 18539458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and molecular docking of some novel anticancer sulfonamides carrying a biologically active pyrrole and pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Nissan YM
    Acta Pol Pharm; 2014; 71(4):603-14. PubMed ID: 25272886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.